Pear therapeutics careers
WebPear Therapeutics Careers Wellfound (formerly AngelList Talent) Pear Therapeutics Follow View 2 jobs Overview People Funding Creating a better world by pioneering software as treatment for serious disease Pear Therapeutics is … WebMay 12, 2024 · BOSTON--(BUSINESS WIRE)-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the expansion of its program to offer patients seeking treatment for addiction access to a telehealth provider through its “find a provider …
Pear therapeutics careers
Did you know?
WebMar 17, 2024 · Pear’s stock closed at 39 cents a share on Friday, down 34% from 59 cents at yesterday’s close. The Boston-based company had raised $250 million in venture funding from investors including ... WebJun 30, 2024 · Interviews at Pear Therapeutics Experience Positive 27% Negative 60% Neutral 13% Getting an Interview Applied online 42% Recruiter 33% Staffing Agency 17% Difficulty 3.0 Average Hard Average Easy Interviews for Top Jobs at Pear Therapeutics Software Engineer (2) Customer Service Representative (2) Full Stack Engineer (2)
WebPear Therapeutics has raised a total of $409M in funding over 8 rounds. Their latest funding was raised on Dec 3, 2024 from a Post-IPO Equity round. Pear Therapeutics is registered under the ticker NASDAQ:PEAR . Pear Therapeutics is funded by 23 investors. Trustbridge Partners and Pritzker/Vlock Family Office are the most recent investors. WebPear Therapeutics operates in the Healthtech industry. The company is located in Boston, MA. Pear Therapeutics was founded in 2013. It has 216 total employees. To see all jobs at Pear Therapeutics, click here. Email For Later Similar Jobs
WebPear Therapeutics Inc. SEC filings breakout by MarketWatch. View the PEAR U.S. Securities and Exchange Commission reporting information. WebMar 14, 2024 · Pear Therapeutics, Inc. Class A Common Stock (PEAR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
WebJun 29, 2024 · Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.
cymbaink 047 laser cartridgeWeb1 day ago · Pear Therapeutics (NASDAQ: PEAR) stock is falling on Friday after the company’s recent bankruptcy filing continues to weigh on its shares. Pear Therapeutics announced its bankruptcy filing while ... cymba and cavumWebMar 21, 2024 · Pear Therapeutics Response Chief People Officer Thank you for taking the time to provide feedback. We’d love to learn more about your experience and how we can improve. Please don’t hesitate to reach out with specific questions to your manager, leadership, or email us at [email protected]. 4.0 ★★★★★ Former Employee, … cymba cavityWebFind out what works well at Pear Therapeutics from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for … cymba integrated solutionsWebPear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. Boston, Massachusetts, United States 101-250 Post-IPO Equity Public peartherapeutics.com/ 4,062 Highlights Stock Symbol NASDAQ:PEAR Total Funding Amount $409M Contacts 148 Employee Profiles 15 … cymba bay therapeuticsWebApr 13, 2024 · Pear Therapeutics set huge revenue goals — but never came close Pear Therapeutics said it would grow from $4 million in 2024 to a whopping $125 million by … cymba charity ukWebApr 13, 2024 · Digital therapeutics industry pioneer, Pear Therapeutics, filed for bankruptcy last week. Despite creating 3 FDA cleared evidence based prescription therapeutics for … cymax swivel bar stools